Ricerc@Sapienza

Donor steatosis represents a well-known risk factor for primary non-function, early allograft dysfunction, and biliary complications after liver transplantation (LT). Recently, machine perfusion (MP) technology has been implemented in the clinical practice, with the primary intent to assess the graft quality and to optimize the organ selection process. A limited number of articles has been published specifically investigated the role of MP in steatotic livers, with few of them looking at the role of hypothermic MP.